The Pennant Group (NASDAQ:PNTG - Get Free Report) issued an update on its FY 2025 earnings guidance on Thursday morning. The company provided earnings per share guidance of 1.030-1.110 for the period, compared to the consensus earnings per share estimate of 1.080. The company issued revenue guidance of $800.0 million-$865.0 million, compared to the consensus revenue estimate of $816.2 million.
The Pennant Group Stock Down 1.1 %
The Pennant Group stock traded down $0.24 during midday trading on Monday, reaching $22.53. The stock had a trading volume of 263,187 shares, compared to its average volume of 197,272. The firm's fifty day simple moving average is $26.51 and its 200-day simple moving average is $30.48. The Pennant Group has a 1-year low of $18.12 and a 1-year high of $37.13. The stock has a market capitalization of $773.86 million, a P/E ratio of 33.13, a price-to-earnings-growth ratio of 2.24 and a beta of 1.91. The company has a debt-to-equity ratio of 0.58, a quick ratio of 1.12 and a current ratio of 1.12.
Wall Street Analyst Weigh In
A number of research firms have weighed in on PNTG. Truist Financial decreased their price target on The Pennant Group from $38.00 to $32.00 and set a "hold" rating for the company in a research note on Monday, January 6th. Wells Fargo & Company began coverage on The Pennant Group in a research note on Thursday, December 19th. They issued an "equal weight" rating and a $33.00 price target for the company. Finally, Oppenheimer raised their price target on The Pennant Group from $34.00 to $37.00 and gave the company an "outperform" rating in a research note on Friday, November 8th. Two research analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. According to MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average price target of $36.00.
Get Our Latest Research Report on PNTG
About The Pennant Group
(
Get Free Report)
The Pennant Group, Inc provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling services for the physical, spiritual, and psychosocial needs of terminally ill patients and their families.
Read More
Before you consider The Pennant Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and The Pennant Group wasn't on the list.
While The Pennant Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
